Lexicon Pharmaceuticals
LXRX
#6704
Rank
A$1.14 B
Marketcap
A$2.58
Share price
10.56%
Change (1 day)
17.98%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2023 (TTM): A-$1.02

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is A-$0.22. In 2022 the company made an earnings per share (EPS) of A-$0.88 an increase over its 2021 EPS that were of A-$0.88.

EPS history for Lexicon Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A-$1.0215.58%
2022A-$0.88-0%
2021A-$0.8810.91%
2020A-$0.80-145.08%
2019A$1.77-206.09%
2018A-$1.67-5.74%
2017A-$1.77-10.95%
2016A-$1.982640%
2015A-$0.07242-96.34%
2014A-$1.98-2.53%
2013A-$2.03-9.09%
2012A-$2.23-37.14%
2011A-$3.550%
2010A-$3.55-39.66%
2009A-$5.883.57%
2008A-$5.68-8.2%
2007A-$6.18-24.69%
2006A-$8.2142.11%
2005A-$5.78-22.97%
2004A-$7.50-35.09%
2003A-$11.56-0%
2002A-$11.5662.86%
2001A-$7.10-19.54%
2000A-$8.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
A$27.51-12,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$8.53-4,026.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$60.70-28,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
A-$8.46 3,793.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$14.50-6,773.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A-$0.02897-86.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
A-$1.09 400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.55-353.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A-$42.42 19,426.67%๐Ÿ‡บ๐Ÿ‡ธ USA